Race Receives $2.8m RD Tax Refund

27 November 2025 – Race Oncology Limited (“Race”) is pleased to announce that it has received $2,787,473 via the Research & Development (R&D) Tax Incentive from the Australian Taxation Office (ATO) for the financial year ended 30 June 2025 (FY2025). An additional refund for FY2025 is expected in early 2026 once final assessment of Race’s eligible overseas R&D activities is completed by the ATO. Th